SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-019364
Filing Date
2024-05-15
Accepted
2024-05-14 21:20:17
Documents
59
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 669381
2 ex31-1.htm EX-31.1 19202
3 ex31-2.htm EX-31.2 18925
4 ex32.htm EX-32 10042
  Complete submission text file 0001493152-24-019364.txt   4143423

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE envb-20240331.xsd EX-101.SCH 40464
6 XBRL CALCULATION FILE envb-20240331_cal.xml EX-101.CAL 51252
7 XBRL DEFINITION FILE envb-20240331_def.xml EX-101.DEF 128617
8 XBRL LABEL FILE envb-20240331_lab.xml EX-101.LAB 333114
9 XBRL PRESENTATION FILE envb-20240331_pre.xml EX-101.PRE 243503
62 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 517448
Mailing Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103 239-302-1707
Enveric Biosciences, Inc. (Filer) CIK: 0000890821 (see all company filings)

IRS No.: 954484725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38286 | Film No.: 24946786
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)